A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CASPAR / ClASsification for Psoriatic ARthritis

[Related PubMed/MEDLINE]
Total Number of Papers: 48
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CASPAR  (>> Co-occurring Abbreviation)
Long Form:   ClASsification for Psoriatic ARthritis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study. CVEs, CVR, CVRFs, MONALISA, PsA
2021 Validation of Sinhala version of Psoriasis Epidemiology Screening Tool. PEST, PsA
2021 [Typical arthritis of the hands : Psoriatic arthritis]. MRI, PsA, SkiBo, SpA
2020 Correlation of serum protein biomarkers with disease activity in psoriatic arthritis. MBDA, PsA, RA, UCSD
2020 Validation of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire in a Turkish psoriatic population. PsA, PsO, ROC, SiPAS
2019 Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study. MCS, mRDCI, PCS, PsA, QoL
2019 Initial assessment of the early arthritis for psoriatic patients diagnostic questionnaire in dermatology clinics in Australia, Korea and China. EARP, PsA
2019 Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study. DIP, PsA
2019 Residual Disease Activity and Associated Factors in Psoriatic Arthritis. BSA, DAPSA, LDA, MDA, PASI, PsA, RDA, VAS, VLDA
10  2019 Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. ACR20, TNFi
11  2019 Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis. DAPSA, PsAID, VLDA
12  2018 Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. csDMARD, JAK1
13  2017 Could Psoriatic Arthritis Be Easily Diagnosed from Current Suspicious Physical Findings in the Dermatology Clinic? NAPSI, PASI, PsA
14  2017 Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study. anti-TNF, CRP, cs, DMARDs, MDA, OR, PsA, PsAID
15  2017 Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population. CPDAI, DAPSA, DAS28, DLQI, ESR, MDA, PASDAS, PASI, PsA, SDAI
16  2017 Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors. FACIT-Fatigue, HAQ, HC, PsA, PSQI
17  2016 Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors. anti-TNF, axPsA, BASDAI, CPDAI, DAPSA, MDA, PR
18  2016 Association of IL1Beta (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis. BASDAI, CRP, DAS28, ESR, PsA
19  2015 A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. ASAS, axSpA, BASDAI, BASFI, CDAI, PsA, RA, RAPID3
20  2015 Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-alpha Drugs. DAPSA, MDA, PsA
21  2015 Patient's Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity? DAPSA, LDA, MDA, PsA, PtGA, TNF-alpha
22  2015 Prevalence of Psoriatic Arthritis in Primary Care Patients With Psoriasis. PsA
23  2015 Relationship of Psoriatic Arthritis to Other Spondyloarthritides. PsA
24  2015 Summary of Sensitivity and Specificity for Psoriatic Arthritis in a South African Cohort according to Classification Criteria. PsA
25  2014 High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. IR, MetS, PsA
26  2014 Immunoglobulin G subclass analysis in psoriatic arthritis. IgG, MGUS, PsA
27  2014 Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? PASI, PsA
28  2014 Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis. NAPSI, PASI, PsA
29  2014 Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. ASAS, PsA
30  2013 Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). DAPSA, DAS28, MDA, PsA, SwePsA
31  2013 Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. ACR, AE, IL, PsA, SAEs
32  2012 Construct validity of the modified numeric rating scale of patient global assessment in psoriatic arthritis. DAS28, HAQ, NRS, PGA, PsA
33  2012 Distinguishing inflammatory from noninflammatory arthritis, enthesitis, and dactylitis in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. GRAPPA, PsA
34  2012 On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting. GRAPPA, PsA
35  2012 Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting. PsA
36  2012 Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting. GRAPPA, PsA
37  2012 Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology. PAIR, PsA
38  2012 Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. PsA
39  2012 The need to define musculoskeletal inflammation: a report from the GRAPPA 2010 annual meeting. PsA
40  2011 Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. DIP, PsA
41  2011 The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study. PsA
42  2010 Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. JANF, PsA
43  2010 Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis. ASAS, ESSG, MRI
44  2009 Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population. ESSG
45  2009 Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. HR, PsA
46  2009 Psoriatic arthritis sine psoriasis. PsA
47  2009 Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. CI, PsA
48  2006 Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. PsA